The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)

Cited by (135)

Items 101–135 of 135

1. Major depressive disorder with subthreshold hypomanic (mixed) features: A real-world assessment of treatment patterns and economic burden
   McIntyre, Roger S., Ng-Mak, Daisy, Chuang, Chien-Chia, Halpern, Rachel, Patel, Pankaj A., Rajagopalan, Krithika, Loebel, Antony · 2017 · Journal of Affective Disorders
2. Behavioural activation therapy for depression in adults with non-communicable diseases
   Uphoff, Eleonora, Pires, Malini, Barbui, Corrado, Barua, Deepa, Churchill, Rachel, Cristofalo, Doriana, Ekers, David, Fottrell, Edward, Mazumdar, Papiya, Purgato, Marianna et al. · 2020 · Cochrane Database of Systematic Reviews
3. Anxiety sensitivity cognitive concerns drive the relation between anxiety sensitivity and symptoms of depression
   Saulnier, Kevin G., Allan, Nicholas P., Raines, Amanda M., Schmidt, Norman B. · 2018 · Cognitive Behaviour Therapy
4. Suppression of reward-induced dopamine release in the nucleus accumbens in animal models of depression: Differential responses to drug treatment
   Minami, Saki, Satoyoshi, Hiroshi, Ide, Soichiro, Inoue, Takeshi, Yoshioka, Mitsuhiro, Minami, Masabumi · 2017 · Neuroscience Letters
5. Abnormal stress responsiveness and suicidal behavior: a risk phenotype
   Steinberg, Louisa J., Mann, J. John · 2020 · Biomarkers in Neuropsychiatry
6. Mental health treatment dose and annual healthcare costs in patients with cancer and major depressive disorder.
   Mausbach, Brent T., Bos, Taylor, Irwin, Scott A. · 2018 · Health Psychology
7. The Societal Value of Broader Access to Antiobesity Medications
   Kabiri, Mina, Sexton Ward, Alison, Ramasamy, Abhilasha, van Eijndhoven, Emma, Ganguly, Rahul, Smolarz, B. Gabriel, Zvenyach, Tracy, Goldman, Dana P., Baumgardner, James R. · 2020 · Obesity
8. Repetitive transcranial magnetic stimulation may be a cost‐effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder
   Zemplényi, Antal, Józwiak-Hagymásy, Judit, Kovács, Sándor, Erdősi, Dalma, Boncz, Imre, Tényi, Tamás, Osváth, Péter, Voros, Viktor · 2022 · BMC Psychiatry
9. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel
   Sharman Moser, Sarah, Chodick, Gabriel, Gelerstein, Shulamit, Barit Ben David, Nava, Shalev, Varda, Stein-Reisner, Orit · 2022 · BMC Psychiatry
10. Global burden of depression and anxiety disorders in older adults, 1990-2019: An analysis of age-period-cohort and temporal-spatial patterns
    Li, Ruyu, Zhou, Xiaoding, Wang, Xiaonan, Cheng, Peixia, Xu, Jiaying, Cao, Jinhong, Gao, Qi, Zhu, Huiping · 2025 · Journal of Affective Disorders
11. Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST‐MST): study protocol for a randomized non‐inferiority trial of magnetic seizure therapy versus electroconvulsive therapy
    Daskalakis, Zafiris J., Tamminga, Carol, Throop, Alanah, Palmer, Lucy, Dimitrova, Julia, Farzan, Faranak, Thorpe, Kevin E., McClintock, Shawn M., Blumberger, Daniel M. · 2021 · Trials
12. The burden associated with, and management of, difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom
    Costa, Tiago, Menzat, Bayar, Engelthaler, Tomas, Fell, Benjamin, Franarin, Tarso, Roque, Gloria, Wei, Yiran, Zhang, Xinyue, McAllister-Williams, R Hamish · 2022 · Journal of Psychopharmacology
13. Breathing-focused Yoga as Augmentation for Unipolar and Bipolar Depression: A Randomized Controlled Trial: Le yoga axé sur la respiration comme traitement d’appoint pour la dépression unipolaire et bipolaire: Un essai randomisé contrôlé
    Ravindran, Arun V., McKay, Martha S., Silva, Tricia da, Tindall, Claudia, Garfinkel, Tiffany, Paric, Angela, Ravindran, Lakshmi · 2021 · The Canadian Journal of Psychiatry
14. Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
    Touya, Maëlys, Lawrence, Debra F., Kangethe, Anne, Chrones, Lambros, Evangelatos, Themmi, Polson, Michael · 2022 · BMC Psychiatry
15. Advancing depression management through biomarker discovery with a focus on genetic and epigenetic aspects: a comprehensive study on neurobiological, neuroendocrine, metabolic, and inflammatory pathways
    Milic, Jelena, Jovic, Sladjana, Sapic, Rosa · 2025 · Genes
16. Specificity of anhedonic alterations in resting-state network connectivity and structure: A transdiagnostic approach
    Geller, Whitney N., Liu, Kevin, Warren, Stacie L. · 2021 · Psychiatry Research Neuroimaging
17. Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence
    2020 · Advances in Pharmacology
18. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality
    Kim, Donghee, Manikat, Richie, Shaikh, Anjiya, Cholankeril, George, Ahmed, Aijaz · 2024 · European Journal of Clinical Investigation
19. Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study
    McIntyre, Roger S., Prieto, Rita, Schepman, Patricia, Yeh, Yu-Chen, Boucher, Matthieu, Shelbaya, Ahmed, Chambers, Richard, Gao, Xin, Pappadopulos, Elizabeth · 2019 · Current Medical Research and Opinion
20. Brief Psychological Intervention Through Mobile App and Conference Calls for the Prevention of Depression in Non-Professional Caregivers: A Pilot Study
    Otero, Patricia, Hita, Isabel, Torres, Ángela J., Vázquez, Fernando L. · 2020 · International Journal of Environmental Research and Public Health
21. Using the goal attainment scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: A phase 4, single-arm, open-label, multicenter study
    McCue, Maggie, Sarkey, Sara, Eramo, Anna, François, Clement, Parikh, Sagar V. · 2021 · BMC Psychiatry
22. Moving towards the benign: automatic interpretation bias modification in dysphoria
    Cowden Hindash, Alexandra H., Rottenberg, Jonathan A. · 2017 · Behaviour Research and Therapy
23. Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study
    Jensen, Kristoffer Jarlov, Gronemann, Frederikke Hørdam, Ankarfeldt, Mikkel Zöllner, Jimenez-Solem, Espen, Alulis, Sarah, Riise, Jesper, Bødker, Nikolaj, Osler, Merete, Petersen, Janne · 2022 · PLOS ONE
24. Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial
    Giosan, Cezar, Cobeanu, Oana, Mogoaşe, Cristina, Szentágotai Tătar, Aurora, Mureşan, Vlad, Boian, Rareș · 2016 · Trials
25. Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial
    Ang, Yuen-Siang, Bruder, Gerard E., Keilp, John G., Rutherford, Ashleigh, Alschuler, Daniel M., Pechtel, Pia, Webb, Christian A., Carmody, Thomas, Fava, Maurizio, Cusin, Cristina et al. · 2022 · Psychological Medicine
26. Heart Rate Variability Predicts Treatment Outcome in Major Depression
    2017 · Journal of Psychiatry and Brain Science
27. Understanding psychological treatment barriers, preferences and histories of individuals with clinically significant depressive symptoms in Australia: a preliminary study
    Smith, Sinead, Paparo, Josephine, Wootton, Bethany M. · 2021 · Clinical Psychologist
28. Dissemination and Implementation of Cognitive Behavioral Therapy for Depression in the Kaiser Permanente Health Care System: Evaluation of Initial Training and Clinical Outcomes
    Karlin, Bradley E., Brown, Gregory K., Jager-Hyman, Shari, Green, Kelly L., Wong, Michi, Lee, Diane S., Bertagnolli, Andrew, Ross, Thekla Brumder · 2019 · Behavior Therapy
29. Acceptance of smart sensing: a barrier to implementation—results from a randomized controlled trial
    Terhorst, Yannik, Weilbacher, Nadine, Suda, Carolin, Simon, Laura, Messner, Eva-Maria, Sander, Lasse Bosse, Baumeister, Harald · 2023 · Frontiers in Digital Health
30. Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms
    Earleywine, Mitch, Altman, Brianna R., De Leo, Joseph · 2022 · Journal of Psychoactive Drugs
31. Telephone coaching for the prevention of depression in farmers: Results from a pragmatic randomized controlled trial
    Thielecke, Janika, Buntrock, Claudia, Titzler, Ingrid, Braun, Lina, Freund, Johanna, Berking, Matthias, Baumeister, Harald, Ebert, David D · 2024 · Journal of Telemedicine and Telecare
32. Do Unified Protocol modules exert general or unique effects on anxiety, depression, and transdiagnostic targets?
    Southward, Matthew W., Lane, Sean P., Shroyer, Sara E., Sauer-Zavala, Shannon · 2023 · Journal of Mood & Anxiety Disorders
33. Functional outcomes with bright light in monotherapy and combined with fluoxetine in patients with major depressive disorder: Results from the LIFE-D trial
    Li, Victor W., Morton, Emma, Michalak, Erin E., Tam, Edwin M., Levitt, Anthony J., Levitan, Robert D., Cheung, Amy, Morehouse, Rachel, Ramasubbu, Rajamannar, Yatham, Lakshmi N. et al. · 2022 · Journal of Affective Disorders
34. An Ecological Study of a Universal Employee Depression Awareness and Stigma Reduction Intervention: “Right Direction”
    Doty, Benjamin, Grzenda, Adrienne, Hwang, Seungyoung, Godar, Sean, Gruttadaro, Darcy, Hauge, Kimberly A., Sherman, Bruce, Clarke, Diana E. · 2021 · Frontiers in Psychiatry
35. The durability of response to transcranial magnetic stimulation in veterans with major depressive disorder
    Lisha, Ijoni, Godbole Kroger, Nupur B., Tsalatsanis, Athanasios, Norred, Michael A., Daneman, Lauren E.W., Tindall, Brianna, Grewal, Eric P., Araque, Samuel Mendez, Zuschlag, Zachary D. · 2026 · Journal of Affective Disorders